药物临床试验登记与信息公示平台数据显示,石药集团欧意药业有限公司的西格列汀二甲双胍缓释片(50mg/500mg)随机、开放、两制剂、单剂量、两周期、交叉健康人体空腹/餐后状态下生物等效性试验已启动。临床试验登记号为CTR20254141,首次公示信息日期为2025年10月22日。该药物剂型为片剂,用法用量为单次给药1片,每周期服药1次,共两周期。本次试验主要目的为考察受试制剂与参比制剂在健康人体内...
Source Link药物临床试验登记与信息公示平台数据显示,石药集团欧意药业有限公司的西格列汀二甲双胍缓释片(50mg/500mg)随机、开放、两制剂、单剂量、两周期、交叉健康人体空腹/餐后状态下生物等效性试验已启动。临床试验登记号为CTR20254141,首次公示信息日期为2025年10月22日。该药物剂型为片剂,用法用量为单次给药1片,每周期服药1次,共两周期。本次试验主要目的为考察受试制剂与参比制剂在健康人体内...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.